Skip to main content
PepStack
Blutwerte · Marker

AST (GOT)

Aspartat-Aminotransferase · ASAT · GOT · SGOT

Leberwerte
Einheit:
IU/L
Abbreviation
AST / GOT

AST quantifies the enzyme activity involved in amino acid metabolism, particularly in the liver and muscle tissues.

Reference Ranges

Reference
10–40IU/L
10
40
LowNormalHigh
Reference
Unit · IU/L

Reference ranges may vary slightly by laboratory; generally similar for both sexes.

Overview

Übersicht

Aspartate aminotransferase (AST), also known as glutamate oxaloacetate transaminase (GOT), is an enzyme found in various tissues, including the liver, heart, and muscles. It plays a crucial role in amino acid metabolism by catalyzing the transfer of an amino group from aspartate to alpha-ketoglutarate, forming oxaloacetate and glutamate. Clinically, AST is a significant marker for liver health, as elevated levels often indicate liver damage or inflammation, such as from hepatitis, cirrhosis, or liver cancer. It is also elevated in conditions affecting other organs, such as myocardial infarction or muscle injury. In the context of athletic performance and biohacking, AST levels can reflect muscle damage from intense exercise, providing insight into recovery needs and potential overtraining. However, interpreting AST levels requires caution, as they can be influenced by factors such as recent physical activity, medications, and other health conditions. Researchers have found that fasting and time of day do not significantly impact AST levels, but it is essential to consider these factors when comparing results over time.

Klinische Bedeutung

Elevated AST levels typically indicate liver damage or inflammation but can also reflect muscle injury or myocardial infarction. Low AST levels are less clinically significant but may occur in vitamin B6 deficiency.

Dynamics

Trend Interpretation

Rising Values

Progressively rising AST values suggest worsening liver or muscle damage. Re-test in 4-6 weeks if elevated.

Falling Values

Falling AST values indicate recovery from liver or muscle injury.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Liver disease
  • Myocardial infarction
  • Muscle injury
  • Hemolysis
  • Alcohol abuse
Cause

Low Levels

  • Vitamin B6 deficiency
  • Chronic kidney disease
  • Malnutrition
  • Severe liver damage
  • Hypothyroidism
Protocol

How to Optimize

Lever

Lifestyle

  • Regular exercise
  • Moderate alcohol consumption
  • Avoidance of hepatotoxic substances
Lever

Nutrition

  • Balanced diet rich in antioxidants
  • Adequate protein intake
  • Hydration
Lever

Supplementation

  • Vitamin B6
  • Milk thistle
  • N-acetylcysteine

Note:

Consult a healthcare provider before starting any supplementation, especially if liver disease is suspected.

Testing Guidelines

✓Fasting Not Required
✓Not Time-Sensitive

Test at the same time of day for consistency; levels may vary slightly throughout the day.

Testing Frequency

Annually for healthy adults, more frequently if monitoring liver health.

Interfering Factors

  • Recent intense exercise
  • Medications like statins
  • Alcohol consumption

Open Research Questions

Current research suggests that reference ranges for AST (GOT) in various populations, particularly in specific disease contexts like leptospirosis and sarcoidosis, remain debated. Researchers have not yet established optimal AST targets for predicting disease severity or outcomes in conditions such as liver fibrosis or invasive infections. Additionally, clinical questions regarding the influence of confounding factors, such as concurrent medications and comorbidities, on AST levels and their interpretation in different clinical scenarios remain unanswered.

48 Research Publications

476

Total Citations

30

Human/RCT

2.5

Avg. Influence

2025

Latest

Sort
Filter
#01

A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19).

ReviewInfluence6.0
148
This meta-analysis summarized biomarkers associated with the severity of COVID-19. Researchers found that ASAT levels were significantly elevated in severe cases, with an odds ratio of 2.27 indicating increased risk. The study suggests that monitoring liver enzymes like ASAT may aid in prognostic risk stratification for COVID-19 patients.
View on PubMed
#02

Use of enzymes for the diagnosis of alcohol-related organ damage.

ReviewInfluence3.0
88
This review discussed the use of serum enzyme levels, including ASAT, in diagnosing alcohol-related organ damage. Researchers noted that elevated ASAT levels can indicate alcohol-induced liver injury, particularly when the ASAT/ALAT ratio exceeds 1.5. The study emphasizes the variability of enzyme markers in diagnosing organ damage.
View on PubMed
#03

Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock.

HumanInfluence2.0
48
Researchers assessed the incidence of hypoxic hepatitis in patients with cardiogenic shock. They found that elevated ASAT levels were an independent predictor of 30-day mortality, with a significant incidence of hypoxic hepatitis observed in the study population. The findings underscore the prognostic relevance of ASAT in these patients.
View on PubMed
#04

Sarcoidosis of the liver: to treat or not to treat?

ReviewInfluence2.0
45
This study explored the effects of ursodeoxycholic acid (UDCA) on patients with hepatic sarcoidosis. Researchers found that serum liver tests, including ASAT levels, improved in patients treated with UDCA compared to those receiving no treatment or corticosteroids. The findings suggest potential benefits of UDCA for symptomatic patients with liver involvement in sarcoidosis.
View on PubMed
#05

The Clinical and Molecular Spectrum of GM1 Gangliosidosis.

HumanInfluence2.0
28
This study analyzed clinical and biochemical data from 22 patients with GM1 gangliosidosis. Researchers found that increased ASAT concentrations were present in 65% of the patients, indicating its potential role in the diagnosis of this condition.
View on PubMed
#06

Sperm morphology and in vitro viability in diluted semen in relation to fertility of AI boars.

Animal
23
Researchers assessed sperm morphology and ASAT release in boars over seven months to relate these factors to fertility. They found that ASAT release was measured in relation to the fertility outcomes of the boars, indicating a potential link between sperm viability and ASAT levels.
View on PubMed
#07

A unifying reference system for clinical enzymology: aspartate aminotransferase and the International Clinical Enzyme Scale.

Review
17
Researchers reviewed methodologies for measuring aspartate aminotransferase (ASAT) and proposed a unifying reference system to improve interlaboratory compatibility. They emphasized the need for standardized enzyme reference materials to ensure consistent ASAT results across different laboratories. This approach aims to enhance the reliability of ASAT measurements in clinical settings.
View on PubMed
#08

Leptospirosis in elderly patients.

HumanInfluence3.0
16
This study analyzed clinical manifestations of leptospirosis in elderly patients. Researchers found that ASAT levels were slightly elevated, indicating hepatic dysfunction, and noted a high mortality rate associated with severe forms of the disease.
View on PubMed
#09

Enhanced cardiac enzyme profile.

HumanInfluence1.0
13
This study proposed a protocol for an enhanced cardiac enzyme profile to improve the diagnosis of myocardial injury. Researchers highlighted the usefulness of ASAT and the ASAT/ALAT ratio in evaluating cardiac conditions, particularly when testing occurs later after symptom onset. The protocol aims to streamline enzyme testing for better diagnostic outcomes.
View on PubMed
#10

Comparison of cage and mast with the alcohol markers CDT, gamma-GT, ALAT, ASAT and MCV.

Human
12
Researchers compared self-reported alcohol consumption questionnaires with laboratory markers for alcohol dependence. They found that ASAT levels, along with other markers, had low sensitivity for diagnosing alcoholism, although they showed high specificity. This study suggests that while alcohol markers can support diagnosis, they may not be reliable screening tools in general hospitals.
View on PubMed

Clinical Trials (1)

1

Total Trials

63

Total Enrolled

Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia

NCT00306202Phase 1COMPLETED
Sponsor

Bristol-Myers Squibb

Enrollment

63

Started

2006

Primary outcome

Recommended Phase II Dose of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia

Leukemia

Publication Trend

Research publications about AST (GOT) over time

10total
1
'78
1
'80
1
'89
1
'90
1
'92
1
'97
1
'15
3
'26

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer